PHK
PMVP icon

Point72 Hong Kong’s PMV Pharmaceuticals PMVP Stock Holding History

Point72 Hong Kong’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,512
Closed -$113K – 1288
2022
Q3 		$113K Buy
+9,512
New +$137K ﹤0.01% 1201
2022
Q1 		– Sell
-3,785
Closed -$87K – 2228
2021
Q4 		$87K Buy
+3,785
New +$91.5K ﹤0.01% 1207
2020
Q4 		– Sell
-6,291
Closed -$223K – 1984
2020
Q3 		$223K Buy
+6,291
New +$232K 0.02% 428

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Point72 Hong Kong's PMVP Position: Q4 2022 in Review

Point72 Hong Kong sold out of PMV Pharmaceuticals (PMVP) in Q4 2022, closing a stake of 9,512 shares — an estimated $113K sold.

Point72 Hong Kong first reported a position in PMVP in Q3 2020 and held it in 3 quarters. The position peaked at $223K in Q3 2020. 115 funds tracked by Wall St. Rank hold PMVP as of Q4 2022.

  • Point72 Hong Kong reported no remaining PMV Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 9,512 PMV Pharmaceuticals shares in Q4 2022, an estimated $113K.
  • Point72 Hong Kong first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Point72 Hong Kong's PMV Pharmaceuticals position peaked at $223K in Q3 2020.
  • 115 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.